Sonic Incytes Recognized at 2023 LSBC Awards Gala

Sonic Incytes was recognized as a “Company to Watch” at the 25th Annual LSBC Awards Gala, presented by Farris. This recognition underscores Sonic Incytes’ commitment to healthcare innovation and its groundbreaking product, Velacur, which is contributing to the fight against the global epidemic of non-alcoholic fatty liver disease—a condition that impacts nearly 30% of the […]

Sonic Incytes Announces New Non-Dilutive Funding to Enhance Company’s Velacur™️ Medical Device

Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund. INOVAIT is a pan-Canadian network funded by the Government of Canada that invests strategically in projects at the intersection of advanced imaging, minimally-invasive therapies, and artificial intelligence (AI). Through this three-year, non-repayable investment, the Company […]

Metabolic Syndrome: Myths, Assessment Tools, Novel Treatments and More

Metabolic syndrome is a cluster of conditions that increase the risk of many chronic illnesses such as heart disease, stroke, diabetes and liver disease. One-third of US adults have metabolic syndrome, including 80 per cent of those who are obese. This disease is a chronic inflammatory condition and it’s treatable. According to renowned bariatric surgeon […]

Register for Novel Tools for Managing Metabolic Syndrome

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Novel Tools for Managing Metabolic Syndrome. Metabolic syndrome is a growing public health issue affecting 1 in 3 Americans. Left untreated, it greatly increases the risk of many chronic illnesses including diabetes, heart disease, and liver disease. Join renowned bariatric surgeon and […]

Sonic Incytes Appoints New CEO and Chair to Accelerate Growth

Following the closing of its US$7.3M Series A raise in December 2021, the Sonic Incytes Medical Corp. Board of Directors is pleased to announce the appointment of Barry Allen as the new CEO and Natalie Dakers as the new Board Chair to lead the company through its next stage of growth. “Our focus is on […]

Learn about The Power of 3D Liver Ultrasound for NASH Clinical Trials

Join us virtually on December 1 at 10AMPT/12PM CT/1PM ET at the 5th Annual NASH Summit 2021 to learn about The Power of 3D Liver Ultrasound for NASH Clinical Trials, featuring Dr. Stephen Harrison, Medical Director, Pinnacle Clinical Research & President, Summit Clinical Research; and George Aliphtiras, CEO, Sonic Incytes Medical Corp. Key takeaways include: […]

Sonic Incytes Selected to Pitch at Innovative HealthTech Competition

Sonic Incytes Medical Corp. has been selected as one of three finalists at the ADA’s 2021 Silicon Valley Leaders Forum HealthTech Showcase, taking place November 19, 2021 in San Mateo, California. Sponsored by Wilson Sonsini, this year’s event will focus on how health technology equity is enabling care for people living with vulnerable conditions. During […]

Register for Owning NAFLD Via Reimbursement Optimization

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Owning NAFLD Via Reimbursement Optimization. Join former payer Dr. Gary Owens and revenue cycle management expert Satish Malnaik to discover how providers and payers can work together to address the emerging fatty liver disease epidemic, resulting in better patient outcomes with improved […]

A Master Builder of HealthTech that Matters

There is a certain thrill when you find parts and use them to build something new. For Sonic Incytes’ Lead Hardware Engineer Mohammad Honarvar, the whole is truly greater than the sum of its parts. Growing up, Mohammad spent much of his time in his dad’s machine shop, watching him fix everything. It wasn’t long […]